>  Zostavax

Zostavax

Z

ostavax is a vaccine developed and marketed by Merck & Co. to prevent shingles, an extremely painful rash similar to chickenpox. The vaccine was approved by the FDA in May 2006 for adults age 50 or older. The vaccine was financially very successfully for Merck, earning the company billions of dollars.

Unfortunately, despite being very profitable, Zostavax caused many who were vaccinated extremely serious complications. Thousands of Zostavax-related complications and injuries were reported to the FDA, ranging from actually causing shingles to post-herpetic neuralgia, nerve damage, vision loss, hearing loss, vertigo/imbalance, heart attacks, strokes, and even death. These injuries have been seen as early as days after the vaccine and as late as six months after. Based on the frequency and severity of the complications, U.S. Center for Disease Control has recommended that Americans ask their pharmacist for Shingrix, a safer and more effective shingles vaccine, instead of Zostavax.

If you or a loved one were vaccinated for shingles with Zostavax and experienced a serious complication, contact us at 804.466.4412. You may be eligible for compensation.

Kincheloe, Litzenburg & Pendleton, PLLC is pleased to announce that Tim Litzenburg and the firm have been named to the Zostavax litigation national plaintiff’s steering committee.

Kincheloe, Litzenburg & Pendleton, PLLC is also pleased to announce that Tim Litzenburg and the firm have been named to the Zostavax litigation national plaintiff’s steering committee.

Need help with legal issues?

None of the information on this site is intended as legal advice. For specific advice pertaining to your particular situation, please consult an attorney. Nothing contained on the website is or should be construed as legal advice, and your use of this website creates no attorney-client relationship with Kincheloe, Litzenburg & Pendleton, PLLC.  If you choose to contact us through our website about legal services, please understand that it will not constitute an agreement to provide legal services to you nor will such action establish an attorney-client relationship.

Kincheloe, Litzenburg & Pendleton, PLLC is committed to protecting your online privacy. We collect only the information submitted by you directly via our contact form and use that information only to respond to your inquiries and to send you information about the firm and its services. We will not share any information with third-parties without your express permission.

To the extent required by the rules of the Virginia State Bar or the rules of any other state, Kincheloe, Litzenburg & Pendleton, PLLC designates Daniel Kincheloe as the attorney responsible for the website.